NEW YORK, Aug. 1 - InforMax on Wednesday reported a slight improvement in second-quarter losses on top of a nearly 130 percent surge in revenues over the same period last year.

The Bethesda, Md.-based bioinformatics company reported a $0.17 diluted net loss per share, beating by 42 cents its earnings per share over the same period last year and by 1 penny a consensus of analysts polled by Thomson Financial/First Call.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.